3,000 Malaysians Will Be Involved In Phase-3 Clinical Study Of Covid-19 Vaccine From China

The vaccine to be tested was developed by the Institute of Medical Biology Chinese Academy of Medical Sciences (IMBCAMS). According to him, the clinical study will evaluate the safety and effectiveness of the Covid-19 vaccine developed by the institute.

He also mentioned that the study, which is expected to start in December, is conducted by the local Clinical Studies Organization (CRO) and has been registered in the National Medical Research Register (NMRR).

Hopefully, the study goes well and we can start planning on distributing the vaccine to all Malaysians so that life can be back to normal.

Also read: First Distribution Of Covid-19 Vaccine In Malaysia Will Be For Those Aged 18 And Above